## **Core Concept**
Insulin is a key anabolic hormone that regulates glucose and lipid metabolism. One of its effects is to promote the uptake of glucose by cells, particularly muscle and adipose tissue. This process involves various intracellular signaling pathways and changes in ion concentrations.

## **Why the Correct Answer is Right**
Insulin causes an intracellular shift of **potassium ions (K+)**. When insulin binds to its receptor on the cell surface, it activates a signaling cascade that leads to the translocation of glucose transporter type 4 (GLUT4) to the cell surface, increasing glucose uptake. Concurrently, insulin stimulates the sodium-potassium ATPase pump (Na+/K+-ATPase), which pumps sodium out of the cell and potassium into the cell. This results in a decrease in serum potassium levels due to the increased cellular uptake of potassium.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Insulin does not primarily cause an intracellular shift of **sodium ions (Na+)**. In fact, insulin's action on the Na+/K+-ATPase pump results in the efflux of sodium from the cell, not an influx.
- **Option B:** Insulin's primary action related to ion movement is not focused on **chloride ions (Cl-)**, although chloride can move in response to changes in membrane potential caused by shifts in other ions.
- **Option C:** This option is not provided, so we proceed with the understanding that the correct answer relates to potassium.

## **Clinical Pearl / High-Yield Fact**
A clinically relevant point to remember is that insulin can cause **hypokalemia** due to its effect on promoting the intracellular shift of potassium ions. This is particularly important in the management of diabetic ketoacidosis or hyperglycemic hyperosmolar nonketotic syndrome, where administering potassium supplements may be necessary alongside insulin therapy to prevent or treat hypokalemia.

## **Correct Answer:** .